Mimetics of the Peptide β-Strand

被引:36
作者
Glenn, Matthew P. [1 ]
Fairlie, David P. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia
关键词
Peptidomimetic; beta-Strand; Extended; Conformation; Drug; Review;
D O I
10.2174/1389557023405747
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bioactive structures of peptides represent important clues for drug discovery and development although peptides themselves have substantial limitations as drugs. One promising approach to overcoming the limitations of peptides is to progressively replace amide bonds in peptides with non-peptidic constraints that bring drug-like properties like stability and bioavailability to the molecules. These constraints can also be used to mould molecules into shapes which mimic key elements of protein secondary structure that confer bioactivity to protein surfaces. Preorganizing a molecule into the shape recognized by a receptor results in high affinity binding though a considerable entropy saving and is an effective approach to engineering highly bioactive drug leads. One peptide structure, the extended beta strand, has only recently been identified as a fundamental recognition element in physiological processes. Relatively few molecules have been described as constrained mimics of extended peptide conformations. We now summarize some approaches to mimicking peptide beta strands, and illustrate these with examples of bioactive, stable and bioavailable molecules that are conformationally biased to mimic the extended peptide beta strand.
引用
收藏
页码:433 / 445
页数:13
相关论文
共 111 条
[1]   REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES - DESIGN OF HYDROLYTICALLY-STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE [J].
ABBENANTE, G ;
MARCH, DR ;
BERGMAN, DA ;
HUNT, PA ;
GARNHAM, B ;
DANCER, RJ ;
MARTIN, JL ;
FAIRLIE, DP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (41) :10220-10226
[2]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[3]   STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
LIU, BS ;
TOPOL, IA ;
KISO, Y ;
MIMOTO, T ;
MITSUYA, H ;
ERICKSON, JW .
STRUCTURE, 1995, 3 (06) :581-590
[4]   NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .6. DESIGN OF A POTENT, INTRATRACHEALLY ACTIVE, PYRIDONE-BASED TRIFLUOROMETHYL KETONE [J].
BERNSTEIN, PR ;
GOMES, BC ;
KOSMIDER, BJ ;
VACEK, EP ;
WILLIAMS, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :212-215
[5]  
BLACK RA, 1988, J BIOL CHEM, V263, P9437
[6]   Secondary structure peptide mimetics:: Design, synthesis, and evaluation of β-strand mimetic thrombin inhibitors [J].
Boatman, PD ;
Ogbu, CO ;
Eguchi, M ;
Kim, HO ;
Nakanishi, H ;
Cao, BL ;
Shea, JP ;
Kahn, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1367-1375
[7]   NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES [J].
BODE, W ;
HUBER, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :433-451
[8]   Design and asymmetric synthesis of beta-strand peptidomimetics [J].
Boumendjel, A ;
Roberts, JC ;
Hu, E ;
Pallai, PV ;
Rebek, J .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (13) :4434-4438
[9]   DESIGN OF ORALLY-ACTIVE, NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE [J].
BROWN, FJ ;
ANDISIK, DW ;
BERNSTEIN, PR ;
BRYANT, CB ;
CECCARELLI, C ;
DAMEWOOD, JR ;
WOOLSON, SA ;
EDWARDS, PD ;
EARLEY, RA ;
FEENEY, S ;
GREEN, RC ;
GOMES, B ;
KOSMIDER, BJ ;
KRELL, RD ;
SHAW, A ;
STEELMAN, GB ;
THOMAS, RN ;
VACEK, EP ;
VEALE, CA ;
TUTHILL, PA ;
WARNER, P ;
WILLIAMS, JC ;
WOLANIN, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) :1259-1261
[10]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39